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flow, such as during instrumentation of
CPB. Figure 1 demonstrates that as pulmo-
nary blood flow decreases, as evidenced by
carbon dioxide delivery, exhaled NO con-
centrations increased. Summary data from
7 patients indicate that reduction of pulmo-
nary arterial blood flow at the onset of CPB
increases peak exhaled NO levels from 7.4
 1.2 ppb to 13.7  1.5 ppb. These data
confirm in human beings earlier sugges-
tions that pulmonary blood flow is not re-
quired for exhaled NO, which is produced
locally in the lung, and that gas-phase NO
concentrations are influenced by uptake
into the pulmonary circulation and blood.
Where do we go from here? This dis-
cussion highlights the fact that Humpl and
colleagues1 have undertaken a complex
task in attempting to delineate the complex
influence of changes from supernormal to
normal pulmonary blood flow and CPB-
associated partial and transient ischemia-
reperfusion and systemic inflammatory re-
sponse on the pulmonary release of NO
from its many sources. Although exhaled
NO could represent an exciting novel diag-
nostic tool to monitor biochemical events
of crucial importance to cardiac surgery,
important methodologic issues that re-
main.7,8 Moreover, even at this early stage
it is obvious that there will be crucial lim-
itations of the methodology. More con-
trolled studies and continued dialog with
international consensus and society recom-
mendations are needed to clarify these is-
sues in ventilated and critically ill patients.
(Exhaled Biomarkers in mechanically ven-
tilated patients [submitted ATS/ERS
Project, Marczin N, Gustafsson LE, Er-
zurum SC, Choi AM, Risby T, and Schu-
bert J]).
Nandor Marczin, MD, PhD
Harefield, United Kingdom
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Reply to the Editor:
We thank Dr Marczin for his interest in our
work1 and the Editor for an opportunity to
respond.
The first issue raised concerns the meth-
odology of exhaled nitric oxide (NO) anal-
ysis. There are several ways to measure
exhaled NO at a constant flow rate in the
sedated, intubated, and mechanically ven-
tilated patient. These include syringe aspi-
ration sampling as performed by us,1 tidal
breathing profiles, and single-breath con-
trolled-flow techniques.2 The latter is dif-
ficult to apply outside the neonatal period.
We chose the syringe aspiration sampling
method because in our preliminary investi-
gations we found it to be a robust, repro-
ducible technique. Indeed, we confirmed
the reproducibility of the method by find-
ing similar changes after cardiopulmonary
bypass in a previous study investigating
exhaled NO before and after surgical clo-
sure of left-to-right shunts in children.3 In
the most recent study1 we measured ex-
haled NO in an identical manner in both
groups of patients, which suggests that the
observed differences between groups were
independent of the method of NO sam-
pling. The results of Tworetzky and col-
leagues4 are intriguing and fully discussed
elsewhere.1
The next concerns raised by Marczin
are the anatomic origin of exhaled NO and
the relationship to endothelial events. Low
exhalation single-breath flow rates (50
mL/s) are characterized by most exhaled
NO arising in airways by diffusion,
whereas higher flows contain a larger pro-
portion of NO arising in the distal lung.5,6
The syringe sampling was performed to-
ward the end of a mechanical tidal breath,
when flows are high. Thus the exhaled
breath will contain a higher proportion of
NO arising in the alveolar region than
would a slow single-breath exhalation. We
suggest that NO produced in the endothe-
lium of the pulmonary capillary bed may
enter the alveolar space and is reflected in
air sampled distally. Capillary blood vol-
ume has been shown to correlate with ex-
haled NO.7 Notwithstanding the elegant
study by Sartori and coworkers,8 which
was performed in healthy adults, there is
evidence to suggest that endothelial de-
rived NO at least partly contributes to ex-
haled NO levels in cardiovascular dis-
ease.9,10 Indeed, Marczin’s published
position is equivocal on this subject, some-
times for11 and sometimes against.
The influence of cardiopulmonary by-
pass on exhaled nitric oxide levels is likely
to be complex and dependant on the dis-
ease, the surgical procedure performed as
well as the timing of the measurements.
Thus Marczin’s cited examples of adults
undergoing lung transplantation12 or coro-
nary artery surgery with bronchoalveolar
lavage13 may not be comparable to chil-
dren with congenital heart disease. Indeed,
our study is perhaps unique in that cardiac
correction was achieved with the use of
bypass in one group and without in an-
other. The changes in exhaled nitric oxide
thus can be more certainly attributed to
cardiopulmonary bypass than is possible in
other studies.
The changes in pulmonary blood flow
during cannulation for cardiopulmonary
bypass described by Marczin are fascinat-
ing, and we are certain his group will have
the opportunity to submit them for peer
review. However, they are irrelevant to the
investigation we undertook and to our con-
clusions. Stated simply, after closure of an
atrial septal defect exhaled nitric oxide ei-
ther increases or decreases, and it is the
method of closure and sequelae (surgery vs
transcatheter), rather than the hemody-
namic consequence of closure (reduction in
pulmonary blood flow) that influences the
direction of change.
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We agree wholeheartedly with Marc-
zin’s call for continued dialog and interna-
tional consensus, and we look forward to
the recommendations of the proposed task
force.
Ian Adatia, MBChBa
Tilman Humpl, MDa
Philip E. Silkoff, MDb
Division of Cardiology and
Critical Care Medicine
Hospital for Sick Children
University of Toronto
Toronto, Ontario M5G 1X8, Canadaa
National Jewish Medical and Research Center
Denver, CO 80206b
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